Literature DB >> 26269737

Management Issues in the Treatment of an Ameloblastoma with an Atypical Presentation.

Juan José Larrañaga1, Axel Sahovaler1, Pedro Ignacio Picco1, Eduardo Luis Mazzaro1, Marcelo Fernando Figari1.   

Abstract

Benign ameloblastoma (BA) is the most common tumor arising from the odontogenic epithelium. Surgical resection with adequate margins is the mainstay of treatment due to the high index of tumor recurrence when not completely excised. Although locoregional spread has been described in the literature, it is very uncommon. We describe the treatment and follow-up of a 22-year-old woman with multiple recurrences and locoregional spread of a mandibular ameloblastoma who was referred to our center after several tumor resections with subsequent reconstructions. After a complete macroscopical removal of a new recurrence, the mandible was primarily reconstructed. A local homolateral recurrence and a second lesion in the contralateral maxilla were detected after 1-year follow-up and accordingly treated. After 4 years the patient showed a new tumor in the temporal fossa and was reoperated. The histopathology was consistent with a BA in all cases. Even though it is rare, locoregional spread of BA has been reported previously. Recurrences discovered during follow-up may require further resections. A close follow-up is mandatory, and treatment of these cases may result demanding requiring a multiple team approach, including oncologists and radiotherapists.

Entities:  

Keywords:  ameloblastoma; atypical; metastasis

Year:  2015        PMID: 26269737      PMCID: PMC4532564          DOI: 10.1055/s-0035-1549012

Source DB:  PubMed          Journal:  Craniomaxillofac Trauma Reconstr        ISSN: 1943-3875


  19 in total

Review 1.  Metastasizing (malignant) ameloblastoma: review of a unique histopathologic entity and report of Mayo Clinic experience.

Authors:  Scott D Van Dam; Krishnan K Unni; Eugene E Keller
Journal:  J Oral Maxillofac Surg       Date:  2010-10-23       Impact factor: 1.895

2.  [An ameloblastoma with distant metastases].

Authors:  E Steinhäuser
Journal:  Fortschr Kiefer Gesichtschir       Date:  1972

3.  Intraosseous carcinoma arising from mandibular ameloblastoma with progressive invasion and pulmonary metastasis.

Authors:  E Ueta; K Yoneda; A Ohno; T Osaki
Journal:  Int J Oral Maxillofac Surg       Date:  1996-10       Impact factor: 2.789

4.  Ameloblastoma of the mandible with cervical lymph node metastasis.

Authors:  D C Duffey; J W Bailet; A Newman
Journal:  Am J Otolaryngol       Date:  1995 Jan-Feb       Impact factor: 1.808

Review 5.  Delayed soft tissue recurrence after treatment of ameloblastoma in a black African: case report and review of the literature.

Authors:  Ezekiel Taiwo Adebayo; Benjamin Fomete; Emmanuel Oladepo Adekeye
Journal:  J Craniomaxillofac Surg       Date:  2010-07-02       Impact factor: 2.078

Review 6.  Maxillary ameloblastomas: a review of the literature and of a 15-year database.

Authors:  Roger Arthur Zwahlen; Klaus Wilhelm Grätz
Journal:  J Craniomaxillofac Surg       Date:  2002-10       Impact factor: 2.078

7.  Ameloblastic carcinoma of the mandible with metastasis to the skull and lung: advanced imaging appearance including computed tomography, magnetic resonance imaging and positron emission tomography computed tomography.

Authors:  B Devenney-Cakir; B Dunfee; R Subramaniam; D Sundararajan; P Mehra; J Spiegel; O Sakai
Journal:  Dentomaxillofac Radiol       Date:  2010-10       Impact factor: 2.419

Review 8.  Metastasizing ameloblastoma.

Authors:  E H Laughlin
Journal:  Cancer       Date:  1989-08-01       Impact factor: 6.860

9.  Malignant odontogenic tumors: a 22-year experience.

Authors:  David Goldenberg; James Sciubba; Wayne Koch; Ralph P Tufano
Journal:  Laryngoscope       Date:  2004-10       Impact factor: 3.325

10.  Malignant ameloblastoma: a case report of a recent onset of neck swelling in a patient with a previously treated ameloblastoma.

Authors:  T Volong Dao; Jairo A Bastidas; Robert Kelsch; Richard A Kraut
Journal:  J Oral Maxillofac Surg       Date:  2009-12       Impact factor: 1.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.